Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Boyle · SciRah

Researcher profile · Semantic Scholar

T. Boyle

Share profile

T. Boyle — researcher profile on SciRah

h-index: 23
Works: 85
Citations: 2,553

Most-cited papers

Landscape of EGFR -dependent and -independent resistance mechanisms to osimertinib and continuation therapy post-progression in EGFR-mutant NSCLC
X. Le, Sonam Puri, M. Negrao, M. Nilsson +20 more
2018Clinical Cancer Research340 citations Open access
Semantic Scholar
PD-L1 Expression in Lung Cancer
Hui Yu, T. Boyle, Cai-Cun Zhou, D. Rimm +1 more
2016Journal of Thoracic Oncology334 citations Open access
Semantic Scholar
MET IHC is a Poor Screen for MET Amplification or MET exon 14 mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium
R. Guo, L. Berry, D. Aisner, Jamie E. Sheren +7 more
2019Journal of Thoracic Oncology157 citations Open access
Semantic Scholar
Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
M. Pekar-Zlotin, F. Hirsch, L. Soussan-Gutman, M. Ilouze +11 more
2015The Oncologist156 citations Open access
Semantic Scholar
Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis
Carol M. Aherne, C. Collins, J. Masterson, M. Tizzano +6 more
2011Gut133 citations Open access
Semantic Scholar
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer
Hui Yu, C. Batenchuk, A. Badzio, T. Boyle +22 more
2016Journal of Thoracic Oncology127 citations Open access
Semantic Scholar
Proteogenomic landscape of squamous cell lung cancer
P. Stewart, E. Welsh, R. Slebos, B. Fang +24 more
2019Nature Communications108 citations Open access
Semantic Scholar
Phase 1/1b study of pembrolizumab plus vorinostat in advanced/metastatic non-small cell lung cancer
J. Gray, A. Saltos, T. Tanvetyanon, E. Haura +13 more
2019Clinical Cancer Research102 citations Open access
Semantic Scholar
Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing.
P. Wentworth, Anita Datta, D. Blakey, T. Boyle +2 more
1996Proceedings of the National Academy of Sciences of the United States of America86 citations Open access
Semantic Scholar
Hypofractionated Stereotactic Re-Irradiation with Pembrolizumab and Bevacizumab in Patients with Recurrent High Grade Gliomas: Results from a Phase 1 Study.
S. Sahebjam, P. Forsyth, N. Tran, J. Arrington +20 more
2020Neuro-Oncology85 citations Open access
Semantic Scholar
Polypharmacology-based ceritinib repurposing using integrated functional proteomics
B. Kuenzi, L. L. Remsing Rix, P. Stewart, B. Fang +6 more
2017Nature Chemical Biology77 citations Open access
Semantic Scholar
ROS1 Immunohistochemistry Among Major Genotypes of Non—Small-Cell Lung Cancer
T. Boyle, K. Masago, K. Ellison, Y. Yatabe +1 more
2014Clinical Lung Cancer61 citations Open access
Semantic Scholar
Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non–Small-Cell Lung Cancer
S. Ren, Fred R. Hirsch, M. Varella-Garcia, D. Aisner +3 more
2014Journal of Thoracic Oncology55 citations Open access
Semantic Scholar
Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function
Nathan P. Ward, Y. Kang, Aimee Falzone, T. Boyle +1 more
2020Journal of Experimental Medicine51 citations Open access
Semantic Scholar
Phase I study of taminadenant (PBF509/NIR178), an adenosine 2A receptor antagonist, with or without spartalizumab, in patients with advanced non-small cell lung cancer
A. Chiappori, B. Creelan, T. Tanvetyanon, J. Gray +14 more
2022Clinical Cancer Research50 citations Open access
Semantic Scholar
Molecular Pathology of Lung Cancer.
James J. Saller, T. Boyle
2021Cold Spring Harbor Perspectives in Medicine50 citations Open access
Semantic Scholar
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.
Patrick C. Kellish, Daniil E. Shabashvili, Masmudur M. Rahman, Akbar Nawab +13 more
2019Journal of Clinical Investigation48 citations Open access
Semantic Scholar
Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC.
A. Chiappori, Charles C. Williams, B. Creelan, T. Tanvetyanon +13 more
201842 citations
Semantic Scholar
Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer
Li-Ping Zhang, Hui Yu, A. Badzio, T. Boyle +11 more
2015Journal of Thoracic Oncology39 citations Open access
Semantic Scholar
Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in KRAS Wild-Type Pancreatic Cancer
Michael J. Fusco, Daryoush Saeed-Vafa, E. Carballido, T. Boyle +10 more
2021JCO Precision Oncology37 citations Open access
Semantic Scholar
Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer
I. Tunali, Yan Tan, J. Gray, E. Katsoulakis +8 more
2021JNCI Cancer Spectrum36 citations Open access
Semantic Scholar
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma
J. Gray, A. Chiappori, Charles C. Williams, T. Tanvetyanon +14 more
2018Cancer Immunology and Immunotherapy35 citations Open access
Semantic Scholar
Erdafitinib Overcomes FGFR3-TACC3-Mediated Resistance to Osimertinib.
E. Haura, J. K. Hicks, T. Boyle
2020Journal of Thoracic Oncology27 citations Open access
Semantic Scholar
Guideline-Adherent Clinical Validation of a Comprehensive 170-Gene DNA/RNA Panel for Determination of Small Variants, Copy Number Variations, Splice Variants, and Fusions on a Next-Generation Sequencing Platform in the CLIA Setting
T. Boyle, A. Mondal, Daryoush Saeed-Vafa, S. Ananth +8 more
2021Frontiers in Genetics23 citations Open access
Semantic Scholar
Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung Adenocarcinoma
Ya-Yi He, Yan Wang, T. Boyle, S. Ren +6 more
2016Medical Science Monitor20 citations Open access
Semantic Scholar
Preselection of lung cancer cases using FGFR1 mRNA and gene copy number for treatment with ponatinib.
T. Ng, Hui Yu, Derek E. Smith, T. Boyle +8 more
2018Clinical Lung Cancer17 citations Open access
Semantic Scholar
Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012.
T. Boyle, J. Bridge, L. Sabatini, J. Nowak +3 more
2014Archives of Pathology & Laboratory Medicine17 citations Open access
Semantic Scholar
Combination IFNβ and membrane-stable CD40L maximize tumor dendritic cell activation and lymph node trafficking to elicit systemic T-cell immunity
Hong Zheng, Xiao-Qing Yu, Mohammed L. Ibrahim, Dana Foresman +10 more
2023Cancer immunology research14 citations Open access
Semantic Scholar
A community‐based lung cancer rapid tissue donation protocol provides high‐quality drug‐resistant specimens for proteogenomic analyses
T. Boyle, G. Quinn, M. Schabath, T. Muñoz-Antonia +17 more
2019Cancer Medicine14 citations Open access
Semantic Scholar
Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.
J. K. Hicks, James J. Saller, Emilie Wang, T. Boyle +1 more
2017Lung Cancer13 citations
Semantic Scholar
Clinical implications of genetic heterogeneity in multifocal pulmonary adenocarcinomas.
T. Tanvetyanon, T. Boyle
2016Journal of Thoracic Disease13 citations Open access
Semantic Scholar
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)
John H. Lockhart, Hayley D. Ackerman, Kyubum Lee, M. Abdalah +11 more
2023npj Precision Oncology12 citations Open access
Semantic Scholar
Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker
J. Pérez-Morales, Darielys Mejías-Morales, Stephanie Rivera-Rivera, Jonathan N. González-Flores +16 more
2018PLoS ONE12 citations Open access
Semantic Scholar
Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).
A. Saltos, T. Tanvetyanon, B. Creelan, M. Shafique +12 more
202011 citations
Semantic Scholar
Hypoxia-related radiomics predict immunotherapy response: A multi-cohort study of NSCLC
I. Tunali, Yan Tan, J. Gray, E. Katsoulakis +7 more
2020bioRxiv11 citations Open access
Semantic Scholar
EGFR IHC and FISH Correlative Analyses (SQUIRE Trial): necitumumab plus gemcitabine-cisplatin vs gemcitabine-cisplatin in 1st-line squamous NSCLC
F. Hirsch, T. Boyle, N. Thatcher, L. Paz-Ares +8 more
201511 citations
Semantic Scholar
194PPREVALENCE AND PROGNOSTIC SIGNIFICANCE OF SODIUM-DEPENDENT PHOSPHATE TRANSPORTER 2B (NAPI2B) PROTEIN EXPRESSION IN NON-SMALL CELL LUNG CANCER (NSCLC).
M. D'Arcangelo, O. Brustugun, Y. Xiao, Y. Choi +11 more
2014Annals of Oncology11 citations Open access
Semantic Scholar
Integrated proteomics-based physical and functional mapping of AXL kinase signaling pathways and inhibitors define its role in cell migration
Anurima Majumder, S. Hosseinian, Mia Stroud, Emma Adhikari +15 more
2022Molecular Cancer Research10 citations Open access
Semantic Scholar
Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance
T. Boyle, F. Khalil, M. Mino-Kenudson, G. Sica +18 more
2019Applied immunohistochemistry & molecular morphology (Print)10 citations Open access
Semantic Scholar
P1.04-32 Phase I/II Study of the A2AR Antagonist NIR178 (PBF-509), an Oral Immunotherapy, in Patients (pts) with Advanced NSCLC
A. Chiappori, Charles C. Williams, B. Creelan, T. Tanvetyanon +13 more
2018Journal of Thoracic Oncology10 citations Open access
Semantic Scholar
Selpercatinib Overcomes CCDC6-RET-Mediated Resistance to Osimertinib.
M. Shields, J. K. Hicks, T. Boyle, E. Haura +1 more
2021Journal of Thoracic Oncology9 citations Open access
Semantic Scholar
Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy
Saif Zaman, A. Hajiran, G. Coba, T. Robinson +9 more
2019European Urology Focus9 citations Open access
Semantic Scholar
Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results.
A. Saltos, T. Tanvetyanon, B. Creelan, M. Shafique +11 more
2023Journal of Clinical Oncology8 citations
Semantic Scholar
RNA sequencing steps toward the first line
T. Boyle, A. Bossler
2023Cancer8 citations
Semantic Scholar
Clinical Activity of Crizotinib in Lung Adenocarcinoma Harboring a Rare ZCCHC8-ROS1 Fusion.
J. K. Hicks, T. Boyle, L. Albacker, R. Madison +2 more
2018Journal of Thoracic Oncology8 citations Open access
Semantic Scholar
Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosis.
D. Nichols, T. Boyle, D. Noyes, K. Latifi +5 more
2018Journal of Thoracic Disease6 citations Open access
Semantic Scholar
Patient, Caregiver and Physician Perspectives on Participating in a Thoracic Rapid Tissue Donation Program
G. Quinn, R. Pentz, T. Muñoz-Antonia, T. Boyle +11 more
2017Patient Education and Counseling6 citations Open access
Semantic Scholar
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
A. Saltos, B. Creelan, T. Tanvetyanon, A. Chiappori +10 more
2023Lung Cancer5 citations
Semantic Scholar
Distributional range of tumor mutational burden (TMB) across multiple cancer types emphasizing the importance of different cutoff values in different tumor types for clinical interpretation: A consensus statement from the SEQUOIA consortium.
Wojciech Swat, Dibyendu Kumar, T. Boyle, Emily Dalton +13 more
2023Journal of Clinical Oncology5 citations Open access
Semantic Scholar
Abstract 1101: CTNNB1 mutation can mediate resistance to EGFR, ALK and KRAS targeted therapies
Anurima Majumder, Benjamin S. Meyer, J. K. Hicks, T. Boyle +1 more
2022Cancer Research4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Haura×17
Invite
E. Haura — researcher profile on SciRah
James J. Saller×12
Invite
James J. Saller — researcher profile on SciRah
J. Gray×12
Invite
J. Gray — researcher profile on SciRah
B. Creelan×12
Invite
B. Creelan — researcher profile on SciRah

×10

Invite

F. Hirsch — researcher profile on SciRah

T. Tanvetyanon×9

Invite

T. Tanvetyanon — researcher profile on SciRah

Invite

S. Antonia — researcher profile on SciRah

Invite

A. Beg — researcher profile on SciRah

Invite

J. K. Hicks — researcher profile on SciRah

Invite

R. Thapa — researcher profile on SciRah

Dung-Tsa Chen×7

Invite

Dung-Tsa Chen — researcher profile on SciRah

A. Chiappori×7

Invite

A. Chiappori — researcher profile on SciRah